ES2134769T3 - Procedimiento y composicion de humidificacion de tejido. - Google Patents

Procedimiento y composicion de humidificacion de tejido.

Info

Publication number
ES2134769T3
ES2134769T3 ES91901558T ES91901558T ES2134769T3 ES 2134769 T3 ES2134769 T3 ES 2134769T3 ES 91901558 T ES91901558 T ES 91901558T ES 91901558 T ES91901558 T ES 91901558T ES 2134769 T3 ES2134769 T3 ES 2134769T3
Authority
ES
Spain
Prior art keywords
composition
contact
tissue
bio
consistency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901558T
Other languages
English (en)
Inventor
Joseph R Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia Laboratories Bermuda Ltd
Original Assignee
Columbia Laboratories Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd
Application granted granted Critical
Publication of ES2134769T3 publication Critical patent/ES2134769T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8194—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/91—Graft copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION Y UN METODO PARA LA HIDRATACION DE TEJIDO MEMBRANOSO DE LOS MAMIFEROS. LA COMPOSICION UTILIZADA EN ESTE METODO INCLUYE AGUA, UN POLIMERO BIOADHERENTE COMO AGENTE HIDRATANTE, Y PREFERIBLEMENTE, UN AGENTE REALZADOR DE LA CONSISTENCIA. EL BIOADHERENTE ES UN POLIMERO FUNCIONAL CARBOXI RETICULADO, QUE SE ESPONJA EN EL AGUA, PERO NO SE DISUELVE EN ELLA, FIBROSO Y EN PARTICULAS, QUE CONTIENE (A) UNA PLURALIDAD DE UNIDADES REPETIDAS DE LAS CUALES AL MENOS ALREDEDOR DEL 80 POR CIENTO CONTIENEN AL MENOS UNA FUNCIONABILIDAD CARBOXILA, Y (B) ALREDEDOR DEL 0,05 AL 1,5 POR CIEN APROXIMADAMENTE DE UN AGENTE RETICULADOR SUSTANCIALMENTE LIBRE DE POLIETER POLIALQUENILO. EL AGENTE REALZADOR DE LA CONSISTENCIA, CUANDO ESTA PRESENTE ES UN POLIMERO SOLUBLE EN AGUA O AMIONICO DISPERSABLE O NO IONICO. LA COMPOSICION SE PONE EN CONTACTO CON EL TEJIDO A SER HIDRATADO, Y ESTE CONTACTO SE MANTIENE DURANTE UN PERIODO DE TIEMPO SUFICIENTE PARA HIDRATAR LA ZONA EN CONTACTO.
ES91901558T 1989-10-31 1990-10-24 Procedimiento y composicion de humidificacion de tejido. Expired - Lifetime ES2134769T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42975589A 1989-10-31 1989-10-31
US42977089A 1989-10-31 1989-10-31

Publications (1)

Publication Number Publication Date
ES2134769T3 true ES2134769T3 (es) 1999-10-16

Family

ID=27028332

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901558T Expired - Lifetime ES2134769T3 (es) 1989-10-31 1990-10-24 Procedimiento y composicion de humidificacion de tejido.

Country Status (26)

Country Link
US (1) US5968500A (es)
EP (1) EP0500807B1 (es)
JP (1) JP2510052B2 (es)
KR (1) KR100218654B1 (es)
AR (1) AR243728A1 (es)
AT (1) ATE181824T1 (es)
AU (1) AU639069B2 (es)
BR (1) BR9007807A (es)
CA (1) CA2072148C (es)
DE (1) DE69033199T2 (es)
DK (1) DK0500807T3 (es)
ES (1) ES2134769T3 (es)
FI (1) FI103764B1 (es)
GR (1) GR3031288T3 (es)
HU (3) HU227563B1 (es)
IE (1) IE62386B1 (es)
IL (1) IL96148A (es)
MA (1) MA22756A1 (es)
MC (1) MC2204A1 (es)
MY (1) MY105322A (es)
NO (1) NO301362B1 (es)
NZ (2) NZ235903A (es)
PE (1) PE27891A1 (es)
PT (1) PT95729B (es)
RU (1) RU2104034C1 (es)
WO (1) WO1991006283A1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5686094A (en) * 1991-04-01 1997-11-11 Theratech, Inc. Controlled release formulations for the treatment of xerostomia
DE69119217T2 (de) * 1990-08-21 1996-10-31 Theratech Inc Zusammensetzungen zur kontrollierten freigabe
DE4113684B4 (de) * 1991-04-26 2005-02-03 Sommermeyer, Klaus, Dr. Spraybares Mund- und Rachenpflegemittel gegen Trockenheit der Schleimhaut
IT1250748B (it) * 1991-08-02 1995-04-21 Poli Ind Chimica Spa Formulazioni utili per il trattamento della secchezza vaginale
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GR1002418B (el) * 1992-07-29 1996-08-21 Johnson & Johnson Consumer Products Inc. Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
GR1001412B (el) * 1992-10-12 1993-11-30 Poli Ind Chimica Spa Συν?έσεις χρήσιμες δια την ?εραπευτική αγωγή της ξηρότητος του κόλπου.
ES2049665B1 (es) * 1992-10-13 1994-11-01 Poli Ind Chimica Spa Formulaciones utiles para el tratamiento de la sequedad viginal.
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US20040096422A1 (en) * 1997-06-17 2004-05-20 Schwartz Herbert E. Compositions of polyacids and polyethers and methods for their use in reducing pain
US20050074495A1 (en) * 1997-06-17 2005-04-07 Fziomed, Inc. Compositions of polyacids and methods for their use in reducing adhesions
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US7192984B2 (en) * 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
WO2000059516A1 (en) * 1999-04-02 2000-10-12 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6284235B1 (en) 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition
CA2407235A1 (en) * 2000-04-28 2001-11-08 Fziomed, Inc. Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
US6592860B1 (en) * 2000-05-30 2003-07-15 Soluble Systems, Llc Composition and applicator for topical substance delivery
DE10051858A1 (de) * 2000-10-19 2002-06-06 Guenther Beisel Verwendung von biologisch abbaubaren, substituierten Kohlenwasserstoffen deren Ester, Ether und/oder Amide als Nasensalbe oder Nasentropfen zur Prophylaxe von inhalationsallergischen Reaktionen und zur Pflege der Nasenschleimhaut
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
CA2441352C (en) * 2001-02-15 2010-05-25 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
EP1450739A4 (en) * 2001-10-12 2008-12-17 Cns Inc NASAL MOISTURIZING GEL AND APPLICATOR
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7846478B2 (en) * 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
EP1513481A4 (en) * 2002-02-15 2010-10-06 Cns Inc NECK SPRAY
US20030204180A1 (en) * 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
WO2004039339A1 (ja) * 2002-10-31 2004-05-13 Idemitsu Technofine Co., Ltd. 風合い・油分散性に優れた化粧料
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US8703198B2 (en) 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
AU2013277007B2 (en) * 2006-03-01 2016-04-14 Mancini Holdings Pty Ltd Aqueous moisturizers and lubircants and uses thereof
US20090155337A1 (en) * 2007-11-12 2009-06-18 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
US20090214654A1 (en) * 2008-02-21 2009-08-27 Isenburg Jason C Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
US20100016833A1 (en) * 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
GB0905677D0 (en) * 2009-04-01 2009-05-20 Yes Syzygy Ltd Intimate lubrication kit
US20110218517A1 (en) * 2009-10-09 2011-09-08 Ogle Matthew F In vivo chemical stabilization of vulnerable plaque
US8444624B2 (en) 2009-10-19 2013-05-21 Vatrix Medical, Inc. Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
CA2795977A1 (en) * 2010-03-12 2011-09-15 Scott Cordray Method of treatment
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
WO2012158944A1 (en) 2011-05-18 2012-11-22 Vatrix Medical, Inc. Coated balloons for blood vessel stabilization
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
WO2016127020A1 (en) * 2015-02-06 2016-08-11 Noven Pharmaceuticals, Inc. Pressure-sensitive adhesives for transdermal drug delivery
WO2018038472A1 (ko) * 2016-08-25 2018-03-01 문득곤 화장료 조성물 및 피부에 유용성분을 공급하는 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE535125A (es) * 1954-01-25
SE7500077L (sv) * 1974-04-20 1975-10-21 Henkel & Cie Gmbh Anvendning av karboxyl- resp. karboxylat- och aldehydgrupper innehallande polymerer som hudfuktighetsbevarande medel i hudvards- och hudskyddsmedel.
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4548990A (en) * 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US4552755A (en) * 1984-05-18 1985-11-12 Minnesota Mining And Manufacturing Company Substantive moisturizing compositions
JPS6172706A (ja) * 1984-09-18 1986-04-14 Showa Denko Kk 化粧料
JPH0744940B2 (ja) * 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
WO1989000451A1 (en) * 1987-07-15 1989-01-26 Himeji Denshi Kabushiki Kaisha Fluid reforming apparatus
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions

Also Published As

Publication number Publication date
PT95729B (pt) 1998-05-29
DE69033199T2 (de) 1999-10-28
NZ235903A (en) 1996-11-26
WO1991006283A1 (en) 1991-05-16
PT95729A (pt) 1991-09-13
IE903891A1 (en) 1991-05-08
NO301362B1 (no) 1997-10-20
DE69033199D1 (de) 1999-08-12
AU7033191A (en) 1991-05-31
AR243728A1 (es) 1993-09-30
FI921932A0 (fi) 1992-04-29
HU227563B1 (en) 2011-08-29
IL96148A0 (en) 1991-07-18
EP0500807B1 (en) 1999-07-07
RU2104034C1 (ru) 1998-02-10
FI921932A (fi) 1992-04-29
KR920703010A (ko) 1992-12-17
AU639069B2 (en) 1993-07-15
ATE181824T1 (de) 1999-07-15
KR100218654B1 (ko) 1999-09-01
IE62386B1 (en) 1995-01-25
NO921686D0 (no) 1992-04-29
DK0500807T3 (da) 2000-02-07
JPH05504338A (ja) 1993-07-08
US5968500A (en) 1999-10-19
MA22756A1 (fr) 1993-10-01
JP2510052B2 (ja) 1996-06-26
FI103764B (fi) 1999-09-30
GR3031288T3 (en) 1999-12-31
NO921686L (no) 1992-06-29
CA2072148A1 (en) 1991-05-01
IL96148A (en) 1995-08-31
CA2072148C (en) 2002-04-23
EP0500807A1 (en) 1992-09-02
FI103764B1 (fi) 1999-09-30
MY105322A (en) 1994-09-30
NZ272331A (en) 1996-11-26
BR9007807A (pt) 1992-09-29
PE27891A1 (es) 1991-10-29
HU9201465D0 (en) 1992-07-28
HUT68635A (en) 1995-07-28
MC2204A1 (fr) 1992-11-26

Similar Documents

Publication Publication Date Title
ES2134769T3 (es) Procedimiento y composicion de humidificacion de tejido.
ES2050096T3 (es) Composicion humidificante del tejido vaginal.
AR013890A1 (es) Un procedimiento para la incorporacion de silice dentro de un polimero en forma de latex
ES2153908T3 (es) Composiciones para revestimiento con propiedades antirreflectoras y antiempañamiento.
AR013981A1 (es) Terapia de progestina con hemorragia controlada
AR035697A1 (es) Polimero cationico dispersable en agua, un metodo para hacer el mismo y articulos usando los mismos
NO831413L (no) Middel for levering av farmasoeytiske polypeptider.
MX9602545A (es) Esterilizacion con acido peracetico.
ES2168312T3 (es) Utilizacion de angiotensina iii y sus analogos para la reparacion tisular.
ES2067705T3 (es) Composicion cosmetica que contiene como agente espesante un polimero que tiene una baja proporcion de motivos con grupos ionicos.
ES2065024T3 (es) Procedimiento y acondicionamiento para conservar y distribuir por porciones liquido esteril.
TR24208A (tr) Bilhassa kozmetik mustahzarlar alaninda kullanil- maga mahsus koyulastirilmis su
ES2082831T3 (es) Composicion para tratamiento de tejidos con propiedades suavizantes.
ES2098968T3 (es) Cateter urinario externo.
ES2152590T3 (es) Polimero de cloruro de vinilo.
BR9805542A (pt) Folha de limpeza desintegrável em água.
ES2110058T3 (es) Composicion de silicona dispersable en agua.
ES2059300T1 (es) Metodo de hidratacion de tejidos y composicion.
FR2833268B1 (fr) Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
ATE78242T1 (de) Alles enthaltende zusammensetzung fuer die behandlung von kesselwasser.
ES2066253T3 (es) Procedimiento para la reticulacion de polimeros que contienen halogeno.
ES2135237T3 (es) Dispositivo de mando o señalizacion electrica con base de fijacion.
ATE293668T1 (de) Stickstofffreier weichspüler
ES2074418T3 (es) Procedimiento para la solubilizacion de la poli(1-3)glucopiranosa.
ES2085892T3 (es) Composicion suavizante de tejidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500807

Country of ref document: ES